Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From ACC.org


Sep 27, 2019

In this special episode of the View, Dr. Peter Block and Dr. Spencer King discuss highlights from Day 1 of TCT.19, including apixaban vs. warfarin and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndromes (AUGUSTUS ACS) and ticagrelor monotherapy vs. ticagrelor-plus-aspirin in high-risk percutaneous coronary intervention (TWILIGHT).